Swati Piramal, 

Like Biocon, Piramal also faced challenges thanks to regulatory hurdles for the pharma industry in the past year. Under Piramal, Lacto Calamine RENEU, a clinically tested formulation with international patents, was taken to markets abroad, including Canada, the U.S., and Europe. Piramal has continued to hedge her bets in other markets, taking the company’s flagship product Tinefcon (a remedy for psoriasis) to Europe.